Modulatory effect of mannose-binding lectin on cytokine responses: Possible roles in HIV infection

European Journal of Clinical Investigation

Volumn 35, Issue 12, 2005, Pages 765-770

  Heggelund, Lars ^a,c,d,f   Mollnes, T E ^a,e   Espevik, T ^b   Muller F ^a   Kristiansen, K I ^a   Aukrust, P ^a,c,d   Froland S S ^a,c,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Section of Clinical Immunology and Infectious Diseases   (Norway)

^d Research Institute for Internal Medicine   (Norway)

^e Institute of Immunology   (Norway)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

HIV AIDS; Innate immunity; MBL; Toll like receptors

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 120; MANNAN; MANNOSE BINDING LECTIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS RNA;

ADULT; ARTICLE; CELL CULTURE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SACCHAROMYCES CEREVISIAE; SUPERNATANT; VIRUS REPLICATION;

EID: 28944452191     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01579.x     Document Type: Article

References (48)

1. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 2000;68:688-93.
2. Hartshorn KL, Sastry K, White MR, Anders EM, Super M, Ezekowitz RA et al. Human mannose-binding protein functions as an opsonin for Influenza A viruses. J Clin Invest 1993;91:1414-20.
3. Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002;1572:401-13.
4. Garred P, Strom J, Quist L, Taaning E, Madsen HO. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J Infect Dis 2003;188:1394-403.
5. Minchinton RM, Dean MM, Clark TR, Heatley S, Mullighan CG. Analysis of the relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. Scand J Immunol 2002;56:630-41.
6. Kielgast S, Thiel S, Henriksen TB, Bjerke T, Olsen J, Jensenius JC. Umbilical cord mannan-binding lectin and infections in early childhood. Scand J Immunol 2003;57:167-72.
7. Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 2001;285:1316-21.
8. Mullighan CG, Heatley S, Doherty K, Szabo F, Grigg A, Hughes TP et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002;99:3524-9.
9. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001;358:614-8.
10. Peterslund NA, Koch C, Jensenius JC, Thiel S. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001;358:637-8.
11. Kilpatrick DC, McLintock LA, Allan EK, Copland M, Fujita T, Jordanides NE et al. No strong relationship between mannan-binding lectin or plasma ficolins and chemotherapy-related infections. Clin Exp Immunol 2003;134:279-84.
12. Bergmann OJ, Christiansen M, Laursen I, Bang P, Hansen NE, Ellegaard J et al. Low levels of mannose-binding lectin do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induction therapy. Eur J Haematol 2003;70:91-7.
13. Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med 2004;199:1295-9.
14. Alan R, Ezekowitz B. Mannose-binding lectin in prediction of susceptibility to infection. Lancet 2001;358:598-9.
15. Santos IK, Costa CH, Krieger H, Feitosa MF, Zurakowski D, Fardin B et al. Mannan-binding lectin enhances susceptibility to visceral leishmaniasis. Infect Immun 2001;69:5212-5.
16. Hogaboam CM, Takahashi K, Ezekowitz RA, Kunkel SL, Schuh JM. Mannose-binding lectin deficiency alters the development of fungal asthma: effects on airway response, inflammation, and cytokine profile. J Leukoc Biol 2004;75:805-14.
17. Rugonfalvi-Kiss S, Endresz V, Madsen HO, Burian K, Duba J, Prohaszka Z et al. Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin. Circulation 2002;106:1071-6.
18. Garred P, Voss A, Madsen HO, Junker P. Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients. Genes Immun 2001;2:442-50.
19. Ezekowitz RA, Kuhlman M, Groopman JE, Byrn RA. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989;169:185-96.
20. Hart ML, Saifuddin M, Uemura K, Bremer EG, Hooker B, Kawasaki T et al. High mannose glycans and sialic acid on gp120 regulate binding of mannose-binding lectin (MBL) to HIV type 1. AIDS Res Hum Retroviruses 2002;18:1311-7.
21. Haurum JS, Thiel S, Jones IM, Fischer PB, Laursen SB, Jensenius JC. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307-13.
22. Saifuddin M, Hart ML, Gewurz H, Zhang Y, Spear GT. Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1. J Gen Virol 2000;81:949-55.
23. Ying H, Ji X, Hart ML, Gupta K, Saifuddin M, Zariffard MR et al. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses 2004;20:327-35.
24. Boniotto M, Crovella S, Pirulli D, Scarlatti G, Spano A, Vatta L et al. Polymorphisms in the MBL2 promoter correlated with risk of HIV-1 vertical transmission and AIDS progression. Genes Immun 2000;1:346-8.
25. Garred P, Madsen HO, Balslev U, Hofman B, Pedersen C, Gerstoft J et al. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin. Lancet 1997;349:236-40.
26. McBride MO, Fischer PB, Sumiya M, McClure MO, Turner MW, Skinner CJ et al. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 1998;9:683-8.
27. Heggelund L, Mollnes TE, Ueland T, Christophersen B, Aukrust P, Froland SS. Mannose-binding lectin in HIV infection: relation to disease progression and highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003;32:354-61.
28. Prohaszka Z, Thiel S, Ujhelyi E, Szlavik J, Banhegyi D, Fust G. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol Lett 1997;58:171-5.
29. Mollnes TE, Brekke OL, Fung M, Fure H, Christiansen D, Bergseth G et al. Essential role of the C5a receptor in E. coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 2002;100:1869-77.
30. Heggelund L, Muller F, Lien E, Yndestad A, Veland T, Kristiansen KI et al. Increased expression of toll-like receptor 2 on monocytes in HIV infection - possible role in inflammation and viral replication. Clin Infect Dis 2004;39:264-9.
31. Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A et al. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003;188:118-27.
32. Chave JP, Durussel C, Glauser MP, Bille J. Asymptomatic oral yeast carriage in HIV-infected patients: frequency and fluconazole susceptibility profile. Clin Microbiol Infect 1996;1:249-52.
33. Vargas KG, Joly S. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol 2002;40:341-50.
34. Lipke PN, Ovalle R. Cell wall architecture in yeast: new structure and new challenges. J Bacteriol 1998;180:3735-40.
35. Ghezzi MC, Raponi G, Angeletti S, Mancini C. Serum-mediated enhancement of TNF-alpha release by human monocytes stimulated with the yeast form of Candida albicans. J Infect Dis 1998;178:1743-9.
36. Ataoglu H, Dogan MD, Mustafa F, Akarsu ES. Candida albicans and Saccharomyces cerevisiae cell wall mannans produce fever in rats: role of nitric oxide and cytokines. Life Sci 2000;67:2247-56.
37. Dogan MD, Ataoglu H, Ataoglu O, Akarsu ES. Polysaccharide mannan components of Candida albicans and Saccharomyces cerevisiae cell wall produce fever by intracerebroventricular injection in rats. Brain Res Bull 1999;48:509-12.
38. Tada H, Nemoto E, Shimauchi H, Watanabe T, Mikami T, Matsumoto T et al. Saccharomyces cerevisiae- and Candida albicans-derived mannan induced production of tumor necrosis factor alpha by human monocytes in a CD14- and toll-like receptor 4-dependent manner. Microbiol Immunol 2002;46:503-12.
39. Richardson MD, Kokki MH. New perspectives in the diagnosis of systemic fungal infections. Ann Med 1999;31:327-35.
40. Benjamin DK Jr, Garges H, Steinbach WJ. Candida bloodstream infection in neonates. Semin Perinatol 2003;27:375-83.
41. Aukrust P, Muller F, Lien E, Nordøy I, Liabakk NB, Kvale D et al. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999;179:74-82.
42. Rizzardi GP, Marriott JB, Cookson S, Lazzarin A, Dalgleish AG, Barcellini W. Tumour necrosis factor (TNF) and TNF-related molecules in HIV-1+ individuals: relationship with in vitro Th1/Th2-type response. Clin Exp Immunol 1998;114:61-5.
43. Poli G, Fauci AS. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res Hum Retroviruses 1992;8:191-7.
44. Dalgleish AG, O'Byrne KJ. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 2002;84:231-76.
45. + T-cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection. J Infect Dis 2004;190:251-6.
46. Rodes B, Toro C, Paxinos E, Poveda E, Martinez-Padial M, Benito JM et al. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection. AIDS 2004;18:1109-16.
47. Jack DL, Read RC, Tenner AJ, Frosch M, Turner MW, Klein NJ. Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis 2001;184:1152-62.
48. Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol 2003;40:423-9.